;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Spinifex completes venture financing

    Spinifex Pharmaceuticals Pty. Ltd., South Yarra, Australia Business: Neurology Date completed: 4/10/14 Type: Venture financing Raised: Not disclosed Investors: Novo A/S; Canaan Partners; GBS Venture Partners; Brandon …

    Published on 4/14/2014
  • TxCell completes IPO

    TxCell S.A. (Euronext:TXCL), Valbonne, France Business: Autoimmune Date completed: 4/11/14 Type: IPO Raised: 16.2 million ($22.2 million) Shares: 2.9 million Price: 5.58 Shares after offering: 11.4 million Underwriters:…

    Published on 4/14/2014
  • Arca biopharma financial update

    Arca biopharma Inc. (NASDAQ: ABIO), Broomfield, Colo. Business: Cardiovascular Date announced: 4/4/14 Arca filed a shelf registration covering the sale of up to $75 million of its securities. The company, which closed …

    Published on 4/14/2014
  • BVCF financial update

    BVCF, Shanghai, China Business: Finance Date announced: 4/8/14 BVCF closed its third dollar-denominated fund, BVCF III, with about $200 million. The firm (formerly BioVeda China) plans to invest about $5-$25 million in …

    Published on 4/14/2014
  • Catalyst Pharma financial update

    Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), Coral Gables, Fla. Business: Neurology Date announced: 4/8/14 Catalyst Pharmaceutical Partners raised $3.8 million through the sale of 1.7 million shares at $2.21 to …

    Published on 4/14/2014
  • Deerfield Management Co. financial update

    Deerfield Management Co., New York, N.Y. Business: Finance Date announced: 4/7/14 Deerfield Management launched Deerfield Private Design Fund III with about $1.6 billion. The fund will invest in private and public …

    Published on 4/14/2014
  • EpiTherapeutics financial update

    EpiTherapeutics ApS, Copenhagen, Denmark Business: Cancer Date announced: 4/7/14 EpiTherapeutics raised 10.7 million ($14.7 million) in the second close of a series A round, bringing the total raised in the round to 15.…

    Published on 4/14/2014
  • Exact Sciences financial update

    Exact Sciences Corp. (NASDAQ: EXAS), Madison, Wis. Business: Diagnostic Date announced: 4/9/14 Exact Sciences raised $19.1 million through the sale of 1.5 million shares at $12.75 to cover the overallotment from its …

    Published on 4/14/2014
  • Genomic Vision financial update

    Genomic Vision S.A. (Euronext: GV), Paris, France Business: Genomics, Diagnostic Date announced: 4/10/14 Genomic Vision raised 2.8 million ($3.8 million) through the sale of 185,000 shares at 15 to cover the …

    Published on 4/14/2014
  • Piqur financial update

    Piqur Therapeutics AG, Basel, Switzerland Business: Cancer Date announced: 4/8/14 The company raised CHF18 million ($20.2 million) in an extension of a series A round, bringing the total raised in the round to CHF32 …

    Published on 4/14/2014
  • Wilex financial update

    Wilex AG (Xetra:WL6), Munich, Germany Business: Cancer Date announced: 4/10/14 Wilex plans to implement a 1-for-4 reverse stock split. Shareholders will vote on the proposal at a May 23 annual general meeting. Following…

    Published on 4/14/2014
  • Accelerate Diagnostics proposes rights offering

    Accelerate Diagnostics Inc. (NASDAQ:AXDX), Tucson, Ariz. Business: Supply/Service, Diagnostic Date announced: 4/7/14 Type: Rights offering To be raised: $45 million Shares: 2.7 million Price: $16.80 Shares outstanding …

    Published on 4/14/2014
  • Agios proposes follow-on

    Agios Pharmaceuticals Inc. (NASDAQ:AGIO), Cambridge, Mass. Business: Cancer Date announced: 4/10/14 Type: Follow-on To be raised: Up to $75 million Shares: TBD Price prior: $48.42 Underwriters: JPMorgan; Goldman Sachs

    Published on 4/14/2014
  • CymaBay proposes follow-on

    CymaBay Therapeutics Inc. (OTCQB:CYMA), Newark, Calif. Business: Endocrine/Metabolic Date announced: 4/8/14 Type: Follow-on To be raised: Up to $30 million Shares: TBD Price prior: $7 Underwriters: Cowen; Stifel, …

    Published on 4/14/2014
  • Dance Biopharm proposes IPO

    Dance Biopharm Inc., Brisbane, Calif. Business: Endocrine/Metabolic Date announced: 4/9/14 Type: IPO To be raised: Up to $75 million Shares: TBD Price: TBD Underwriters: Wells Fargo; Stifel, Nicolaus; Oppenheimer; Roth …

    Published on 4/14/2014
  • Minerva Neurosciences proposes IPO

    Minerva Neurosciences Inc., Cambridge, Mass. Business: Neurology Date announced: 4/9/14 Type: IPO To be raised: Up to $69 million Shares: TBD Price: TBD Underwriters: Jefferies; Baird; JMP Securities Note: The company …

    Published on 4/14/2014
  • Miraculins proposes private placement of units

    Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date announced: 4/4/14 Type: Private placement of units To be raised: Up to C$500,000 ($455,250) Units: 2 million Price: C$0.25 (unit) …

    Published on 4/14/2014
  • Karyopharm withdraws follow-on

    Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Natick, Mass. Business: Cancer, Inflammation Date announced: 4/7/14 Type: Follow-on Underwriters: BofA Merrill Lynch; Leerink Partners; Wedbush; JMP Securities; Oppenheimer …

    Published on 4/14/2014
  • Cerulean amends IPO

    Cerulean Pharma Inc., Cambridge, Mass. Business: Drug delivery, Cancer Date announced: 3/31/14 Type: IPO To be raised: Up to $74.8 million Shares: 5 million Price: $11-$13 Underwriters: Leerink Partners; Canaccord; JMP …

    Published on 4/7/2014
  • Quotient amends IPO

    Quotient Ltd., Penicuik, U.K. Business: Diagnostic Date announced: 4/3/14 Type: IPO To be raised: Up to $92 million Shares: 5 million Price: $14-$16 Underwriters: UBS; Baird; Cowen Overallotment: 750,000 Note: Quotient,…

    Published on 4/7/2014
  • Scynexis amends IPO

    Scynexis Inc., Research Triangle Park, N.C. Business: Infectious, Ophthalmic Date announced: 4/2/14 Type: IPO To be raised: Up to $67.5 million Shares: 7.3 million Price: $7-$8 Underwriters: RBC Capital Markets; …

    Published on 4/7/2014
  • TxCell amends IPO

    TxCell S.A., Valbonne, France Business: Autoimmune Date announced: 3/31/14 Type: IPO To be raised: Up to 26.4 million ($36.3 million) Shares: 3.9 million Price: 5.58 - 6.82 Overallotment: 667,741 Note: The amended …

    Published on 4/7/2014
  • Aelis Farma completes venture financing

    Aelis Farma S.A.S., Bordeaux, France Business: Neurology, Endocrine/Metabolic, Dermatology Date completed: 3/28/14 Type: Venture financing Raised: 650,000 ($894,270) Investors: Inserm Transfert; Aqui Invest; Aquitaine …

    Published on 4/7/2014
  • AntriaBio completes private placement of units

    AntriaBio Inc. (OTCQB:ANTB), Menlo Park, Calif. Business: Endocrine/Metabolic Date completed: 4/1/14 Type: Private placement of units Raised: $7.3 million Units: 28.1 million Price: $0.26 (unit) Shares after offering: …

    Published on 4/7/2014
  • BG Medicine completes follow-on

    BG Medicine Inc. (NASDAQ: BGMD), Waltham, Mass. Business: Diagnostic Date completed: 4/3/14 Type: Follow-on Raised: $10 million Shares: 6.5 million Price: $1.55 Shares after offering: 34.4 million Underwriter: Lazard …

    Published on 4/7/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993